Event: ESMO 2019

Experts Highlight Anticipated Research to Be Revealed at ESMO 2019

ESMO 2019 – the best bits!

ESMO Congress 2019 - 3DforScience

Petros Grivas, ESMO 2019 - Advances in metastatic urothelial cancer

‘A train to ESMO’ for the climate

John Strickler: ESMO 2019 Highlights

ESMO Congress 2019 Daily Reporter - Editor's Picks: Gastrointestinal cancer

Axel Merseburger, ESMO 2019 - Advances in metastatic hormone-sensitive prostate cancer

Arlene Siefker-Radtke, ESMO 2019 - KEYNOTE-866 Phase III trial in bladder cancer

Lorenza Rimassa, ESMO 2019 - COSMIC-312 study in hepatocellular carcinoma

Dr Marina Maglakelidze Presents HER-Vaxx Trial Data at ESMO 2019

Professor Axel Merseburger at ESMO 2019

Jarrod Longcor: ESMO highlights

Melanoma: what’s new from ESMO 2019?

Andreas Charalambous, ESMO 2019 - EONS Safety Manifesto

MONARCH 2: abemaciclib added to fulvestrant shows OS benefit in HR+/HER2- advanced breast cancer

ESMO 2019: Dr. O'Shaughnessy Highlights Progress in Breast Cancer

Raffaele Califano, ESMO 2019 - FLAURA study in NSCLC

OncLive News Network On Location: ESMO 2019 Day 3

PAOLA-1 Phase 3 data: olaparib plus bevacizumab maintenance for advanced ovarian cancer

Melanoma news from ESMO 19

Optimism for apatinib in gastric cancer

ESMO 2019: Dr. Choueiri Discusses Novel Treatment Strategies in GU Cancers

Department of oncology - Esmo Congress TV